FabRx
FabRx is developing better medicines using patented 3D printing technology to enable medical treatments to be personalised to the individual needs of each patient (in terms of dosage, shape, size and dose combinations) for production on site in pharmacies or clinical trials units.
FabRx was spun out from University College London (UCL) in 2014.